# Biotech Daily Digest — 2026-02-05

**30 items from 4 sources**

## Summary by Source

- Endpoints News: 4 items
- Fierce Biotech: 6 items
- MHRA – News: 1 item
- arXiv q-bio: 19 items


## Endpoints News

- **[Eikon IPO analysis: Big biotech names, big valuation cut](https://endpoints.news/eikon-ipo-analysis-big-biotech-names-big-valuation-cut/)**  
  _Thu, 05 Feb 2026 14:32:16 +0000_  
  For Eikon Therapeutics, its IPO feels more like something it’s surviving rather than celebrating.

 The Bay Area startup is one of biotech’s most prominent privately-held companies, after raising more than $1 billion to advance its ...

- **[Flagship's Generate:Biomedicines files for IPO, pitching AI-driven drugs](https://endpoints.news/flagships-generatebiomedicines-files-for-ipo-pitching-ai-driven-drugs/)**  
  _Thu, 05 Feb 2026 12:00:39 +0000_  
  Just nine days after dosing the first patient in a Phase 3 trial, Generate:Biomedicines has filed for an IPO.

 The Flagship Pioneering-backed startup has become a richly-funded leader of AI bio since its founding in ...

- **[Rare pediatric PRV program reauthorized until 2029 via government funding law](https://endpoints.news/rare-pediatric-prv-program-reauthorized-until-2029-via-government-funding-law/)**  
  _Wed, 04 Feb 2026 18:27:40 +0000_  
  President Donald Trump on Tuesday signed the government funding extension that also reauthorized the FDA's ability to issue rare pediatric priority reviews through 2029, reviving an incentive program that industry has fought to keep.  ...

- **[Updated: Embattled Novo Nordisk considers buying a monthly GLP-1, unveils pipeline cuts](https://endpoints.news/embattled-novo-nordisk-considers-buying-a-monthly-glp-1-to-bolster-portfolio/)**  
  _Wed, 04 Feb 2026 10:55:33 +0000_  
  Novo Nordisk is looking into acquiring or developing a long-acting GLP-1 drug that could compete with Pfizer's monthly obesity shot. It has also cut a handful of drugs from its pipeline, so it certainly has ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/flagship-founded-antibody-biotech-generate-latest-mull-ipo" hreflang="en">Flagship-founded antibody biotech Generate is latest to mull IPO</a>](https://www.fiercebiotech.com/biotech/flagship-founded-antibody-biotech-generate-latest-mull-ipo)**  
  _Feb 5, 2026 8:31am_  
  Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build.

- **[<a href="https://www.fiercebiotech.com/biotech/quell-halts-liver-transplant-treg-trial-focus-preclinical-chill-not-kill-candidate" hreflang="en">Quell halts liver transplant Treg trial to focus on preclinical 'chill not kill' candidate</a>](https://www.fiercebiotech.com/biotech/quell-halts-liver-transplant-treg-trial-focus-preclinical-chill-not-kill-candidate)**  
  _Feb 5, 2026 6:03am_  
  Quell Therapeutics is pressing pause on an engineered regulatory T-cell therapy for liver transplant patients in order to focus resources on a preclinical autoimmune candidate.

- **[<a href="https://www.fiercebiotech.com/biotech/eikons-upsized-381m-nasdaq-listing-marks-largest-biotech-ipo-2024" hreflang="en">Eikon's upsized $381M Nasdaq listing marks largest biotech IPO since 2024</a>](https://www.fiercebiotech.com/biotech/eikons-upsized-381m-nasdaq-listing-marks-largest-biotech-ipo-2024)**  
  _Feb 5, 2026 4:24am_  
  Eikon Therapeutics is heading to the Nasdaq this morning with an upsized $381 million IPO in a further sign of the renewed appeal of the public markets.

- **[<a href="https://www.fiercebiotech.com/biotech/lilly-drops-3-pipeline-drugs-including-gene-therapy-1b-prevail-buyout" hreflang="en">Lilly drops 3 pipeline drugs, including gene therapy from $1B Prevail buyout</a>](https://www.fiercebiotech.com/biotech/lilly-drops-3-pipeline-drugs-including-gene-therapy-1b-prevail-buyout)**  
  _Feb 4, 2026 11:40am_  
  As Eli Lilly awaits an FDA approval decision for its oral GLP-1 orforglipron, the pharma has discarded three clinical-stage drugs, including a gene therapy from its $1 billion acquisition of Prevail Therapeutics.

- **[<a href="https://www.fiercebiotech.com/biotech/novartis-shakes-early-pipeline-6-assets-nixed-and-2-new-cancer-candidates" hreflang="en">Novartis shakes up early pipeline with 6 culls and 2 new cancer candidates</a>](https://www.fiercebiotech.com/biotech/novartis-shakes-early-pipeline-6-assets-nixed-and-2-new-cancer-candidates)**  
  _Feb 4, 2026 11:35am_  
  Novartis has nixed six early-stage pipeline programs, swapping in two new phase 1 cancer candidates as replacements.

- **[<a href="https://www.fiercebiotech.com/biotech/preclinical-stem-cell-biotech-primegen-takes-spac-route-nasdaq" hreflang="en">Preclinical stem cell biotech PrimeGen takes SPAC route to Nasdaq</a>](https://www.fiercebiotech.com/biotech/preclinical-stem-cell-biotech-primegen-takes-spac-route-nasdaq)**  
  _Feb 4, 2026 9:00am_  
  Stem cell therapy biotech PrimeGen US is taking the less-traveled SPAC route to the public markets.


## MHRA – News

- **[Decision: Orphan registered medicinal products](https://www.gov.uk/government/publications/orphan-registered-medicinal-products)**  
  _2026-02-04T13:48:38Z_  
  A list of authorised orphan medicinal products registered by the UK licensing authority.


## arXiv q-bio

- **[All-Atom GPCR-Ligand Simulation via Residual Isometric Latent Flow](https://arxiv.org/abs/2602.03902)**  
  _Thu, 05 Feb 2026 00:00:00 -0500_  
  arXiv:2602.03902v1 Announce Type: new 
Abstract: G-protein-coupled receptors (GPCRs), primary targets for over one-third of approved therapeutics, rely on intricate conformational transitions to transduce signals. While Molecular Dynamics (MD) is essential for elucidating this transduction process, particularly within…

- **[Mathematical simulations of pediatric hemodynamics in isolated ventricular septal defect](https://arxiv.org/abs/2602.04008)**  
  _Thu, 05 Feb 2026 00:00:00 -0500_  
  arXiv:2602.04008v1 Announce Type: new 
Abstract: Computer modeling of the cardiovascular system has potential to revolutionize personalized medical care. This is especially promising for congenital heart defects, such as ventricular septal defect (VSD), a hole between the two ventricles of the heart. However, relative…

- **[A computational account of dreaming: learning and memory consolidation](https://arxiv.org/abs/2602.04095)**  
  _Thu, 05 Feb 2026 00:00:00 -0500_  
  arXiv:2602.04095v1 Announce Type: new 
Abstract: A number of studies have concluded that dreaming is mostly caused by randomly arriving internal signals because "dream contents are random impulses", and argued that dream sleep is unlikely to play an important part in our intellectual capacity. On the contrary, numerou…

- **[A brief review of evolutionary game dynamics in the reinforcement learning paradigm](https://arxiv.org/abs/2602.04150)**  
  _Thu, 05 Feb 2026 00:00:00 -0500_  
  arXiv:2602.04150v1 Announce Type: new 
Abstract: Cooperation, fairness, trust, and resource coordination are cornerstones of modern civilization, yet their emergence remains inadequately explained by the persistent discrepancies between theoretical predictions and behavioral experiments. Part of this gap may arise fro…

- **[Discovering Mechanistic Models of Neural Activity: System Identification in an in Silico Zebrafish](https://arxiv.org/abs/2602.04492)**  
  _Thu, 05 Feb 2026 00:00:00 -0500_  
  arXiv:2602.04492v1 Announce Type: new 
Abstract: Constructing mechanistic models of neural circuits is a fundamental goal of neuroscience, yet verifying such models is limited by the lack of ground truth. To rigorously test model discovery, we establish an in silico testbed using neuromechanical simulations of a larva…

- **[BrainVista: Modeling Naturalistic Brain Dynamics as Multimodal Next-Token Prediction](https://arxiv.org/abs/2602.04512)**  
  _Thu, 05 Feb 2026 00:00:00 -0500_  
  arXiv:2602.04512v1 Announce Type: new 
Abstract: Naturalistic fMRI characterizes the brain as a dynamic predictive engine driven by continuous sensory streams. However, modeling the causal forward evolution in realistic neural simulation is impeded by the timescale mismatch between multimodal inputs and the complex to…

- **[Uncertainty in Island-based Ecosystem Services and Climate Change](https://arxiv.org/abs/2602.04762)**  
  _Thu, 05 Feb 2026 00:00:00 -0500_  
  arXiv:2602.04762v1 Announce Type: new 
Abstract: Small and medium-sized islands are acutely exposed to climate change and ecosystem degradation, yet the extent to which uncertainty is systematically addressed in scientific assessments of their ecosystem services remains poorly understood. This study revisits 226 peer-…

- **[A Hitchhiker's Guide to Poisson Gradient Estimation](https://arxiv.org/abs/2602.03896)**  
  _Thu, 05 Feb 2026 00:00:00 -0500_  
  arXiv:2602.03896v1 Announce Type: cross 
Abstract: Poisson-distributed latent variable models are widely used in computational neuroscience, but differentiating through discrete stochastic samples remains challenging. Two approaches address this: Exponential Arrival Time (EAT) simulation and Gumbel-SoftMax (GSM) relax…

- **[AtlasPatch: An Efficient and Scalable Tool for Whole Slide Image Preprocessing in Computational Pathology](https://arxiv.org/abs/2602.03998)**  
  _Thu, 05 Feb 2026 00:00:00 -0500_  
  arXiv:2602.03998v1 Announce Type: cross 
Abstract: Whole-slide image (WSI) preprocessing, typically comprising tissue detection followed by patch extraction, is foundational to AI-driven computational pathology workflows. This remains a major computational bottleneck as existing tools either rely on inaccurate heurist…

- **[Group Contrastive Learning for Weakly Paired Multimodal Data](https://arxiv.org/abs/2602.04021)**  
  _Thu, 05 Feb 2026 00:00:00 -0500_  
  arXiv:2602.04021v1 Announce Type: cross 
Abstract: We present GROOVE, a semi-supervised multi-modal representation learning approach for high-content perturbation data where samples across modalities are weakly paired through shared perturbation labels but lack direct correspondence. Our primary contribution is GroupC…

- **[Synthesizable Molecular Generation via Soft-constrained GFlowNets with Rich Chemical Priors](https://arxiv.org/abs/2602.04119)**  
  _Thu, 05 Feb 2026 00:00:00 -0500_  
  arXiv:2602.04119v1 Announce Type: cross 
Abstract: The application of generative models for experimental drug discovery campaigns is severely limited by the difficulty of designing molecules de novo that can be synthesized in practice. Previous works have leveraged Generative Flow Networks (GFlowNets) to impose hard s…

- **[Multi-Integration of Labels across Categories for Component Identification (MILCCI)](https://arxiv.org/abs/2602.04270)**  
  _Thu, 05 Feb 2026 00:00:00 -0500_  
  arXiv:2602.04270v1 Announce Type: cross 
Abstract: Many fields collect large-scale temporal data through repeated measurements (trials), where each trial is labeled with a set of metadata variables spanning several categories. For example, a trial in a neuroscience study may be linked to a value from category (a): tas…

- **[How seed banks evolve in plants: a stochastic dynamical system subject to a strong drift](https://arxiv.org/abs/2602.04437)**  
  _Thu, 05 Feb 2026 00:00:00 -0500_  
  arXiv:2602.04437v1 Announce Type: cross 
Abstract: We study how changes in population size and fluctuating environmental conditions influence the establishment of seed banks in plants. Our model is a modification of the Wright-Fisher model with seed bank, introduced by Kaj, Krone and Lascoux. We distinguish between wi…

- **[The impact of heterogeneity on the co-evolution of cooperation and epidemic spreading in complex networks](https://arxiv.org/abs/2602.04481)**  
  _Thu, 05 Feb 2026 00:00:00 -0500_  
  arXiv:2602.04481v1 Announce Type: cross 
Abstract: The dynamics of herd immunity depend crucially on the interaction between collective social behavior and disease transmission, but the role of heterogeneity in this context frequently remains unclear. Here, we dissect this co-evolutionary feedback by coupling a public…

- **[Generative Modeling of Neural Dynamics via Latent Stochastic Differential Equations](https://arxiv.org/abs/2412.12112)**  
  _Thu, 05 Feb 2026 00:00:00 -0500_  
  arXiv:2412.12112v2 Announce Type: replace 
Abstract: We propose a probabilistic framework for developing computational models of biological neural systems. In this framework, physiological recordings are viewed as discrete-time partial observations of an underlying continuous-time stochastic dynamical system which imp…

- **[Flexible MOF Generation with Torsion-Aware Flow Matching](https://arxiv.org/abs/2505.17914)**  
  _Thu, 05 Feb 2026 00:00:00 -0500_  
  arXiv:2505.17914v4 Announce Type: replace 
Abstract: Designing metal-organic frameworks (MOFs) with novel chemistries is a longstanding challenge due to their large combinatorial space and complex 3D arrangements of the building blocks. While recent deep generative models have enabled scalable MOF generation, they ass…

- **[Processing-in-memory for genomics workloads](https://arxiv.org/abs/2506.00597)**  
  _Thu, 05 Feb 2026 00:00:00 -0500_  
  arXiv:2506.00597v2 Announce Type: replace 
Abstract: Low-cost, high-throughput DNA and RNA sequencing (HTS) data is the backbone of the life sciences. Genome sequencing is now becoming a part of Predictive, Preventive, Personalized, and Participatory (termed 'P4') medicine. All genomic data are currently processed in…

- **[Attention Is Not Retention: The Orthogonality Constraint in Infinite-Context Architectures](https://arxiv.org/abs/2601.15313)**  
  _Thu, 05 Feb 2026 00:00:00 -0500_  
  arXiv:2601.15313v2 Announce Type: replace 
Abstract: Biological memory solves a problem that eludes current AI: storing specific episodic facts without corrupting general semantic knowledge. Complementary Learning Systems theory explains this through two subsystems - a fast hippocampal system using sparse, pattern-sep…

- **[Mesoscale tissue properties and electric fields in brain stimulation: Bridging the macroscopic and microscopic scales using layer-specific cortical conductivity](https://arxiv.org/abs/2511.16465)**  
  _Thu, 05 Feb 2026 00:00:00 -0500_  
  arXiv:2511.16465v5 Announce Type: replace-cross 
Abstract: Accurate simulations of electric fields (E-fields) in neural stimulation depend on tissue conductivity representations that link underlying microscopic tissue structure with macroscopic assumptions. Mesoscale conductivity variations can produce meaningful chan…
